Saturable metabolic pathways for ethotoin in man

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Enzymology

Background:

• Ethotoin is an anticonvulsant drug.
• Its elimination in humans exhibits dose-dependent kinetics.
• Understanding these kinetics is crucial for effective therapeutic use.

Purpose of the Study:

• To investigate the mechanism of ethotoin's dose-dependent kinetics.
• To examine the urinary excretion of ethotoin and its metabolites.
• To explore potential enzymatic saturation in drug metabolism.

Main Methods:

• Analysis of urinary excretion patterns of ethotoin and metabolites.
• Studying three patients undergoing continuous ethotoin treatment.
• Administering ethotoin at two distinct dose levels.

Main Results:

• Evidence of partial saturation in the dealkylation metabolic pathway at higher ethotoin doses.
• p-hydroxylation identified as a potentially saturable enzymatic process.
• Michaelis-Menten constants were approximated for enzymatic pathways.

Conclusions:

• Dose-dependent kinetics of ethotoin in humans are likely due to partly saturable enzymatic metabolic pathways.
• Saturation of dealkylation and p-hydroxylation contributes to altered drug clearance at high doses.
• These findings aid in understanding ethotoin's pharmacokinetic variability.